John A Kessler

Title: John A Kessler: Innovator in Neuropathy Treatment

Introduction

John A Kessler is a notable inventor based in New Canaan, CT (US). He has made significant contributions to the field of neuropathy treatment, holding a total of 9 patents. His work focuses on the use of growth factors to address drug-induced neuropathy and peripheral neuropathy.

Latest Patents

One of Kessler's latest patents involves the use of growth factors to treat drug-induced neuropathy. This invention relates to the application of neuronotrophic factors, such as nerve growth factor (NGF), ciliary derived neuronotrophic factor (CNTF), brain derived neuronotrophic factor (BDNF), neuronotrophin-3 (NT-3), fibroblast growth factor (FGF), epidermal growth factor (EGF), transforming growth factor alpha (TGF-α), and transforming growth factor beta (TGF-β) to prevent drug-induced neuropathy. Another significant patent features a method for the prevention and treatment of peripheral neuropathy using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) in mammals.

Career Highlights

Throughout his career, Kessler has worked with esteemed institutions, including Albert Einstein College of Medicine and Cephalon, Inc. His research has contributed to advancements in understanding and treating neuropathic conditions.

Collaborations

Kessler has collaborated with notable colleagues such as Stuart C Apfel and Michael E Lewis. Their combined expertise has furthered research in the field of neuropathy.

Conclusion

John A Kessler's innovative work in the treatment of neuropathy through the use of growth factors has made a significant impact in the medical field. His contributions continue to influence research and treatment strategies for neuropathic conditions.